Jump to a section on this page:
This project uses in vivo two-photon imaging in a mouse model to track chimeric antigen receptor (CAR) T cells as they traffic into brain tumors.
This project investigates whether biomarkers in serum, cerebrospinal fluid, or on brain imaging can predict neurotoxicity risk and measure brain injury in pediatric cancer immunotherapy patients.
We study the effects of CD19-directed CAR T cell therapy on the brain microvasculature in an immunocompetent mouse model.